AVFIX-CV is a combination of Cefixime, a third-generation cephalosporin antibiotic, and
Potassium Clavulanate, a β-lactamase inhibitor. This synergistic formulation enhances the
efficacy of Cefixime by overcoming bacterial resistance caused by β-lactamase-producing
organisms, offering powerful and extended coverage against tough bacterial infections.
Key Benefits:
● Combats resistant bacterial infections with dual-action synergy
● Broad-spectrum efficacy against gram-positive and gram-negative bacteria
● Effective for respiratory, urinary, and ENT infections
● Improved clinical outcomes in recurrent and chronic infections
● Convenient once or twice daily oral dosing
Indications:
● Acute sinusitis and tonsillitis
● Community-acquired pneumonia and bronchitis
● Otitis media (ear infections)
● Uncomplicated urinary tract infections
● Skin and soft tissue infections